• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人补体第四成分的纯化及结构分析

Purification and structural analysis of the fourth component of human complement.

作者信息

Bolotin C, Morris S, Tack B, Prahl J

出版信息

Biochemistry. 1977 May 3;16(9):2008-15. doi: 10.1021/bi00628a039.

DOI:10.1021/bi00628a039
PMID:322709
Abstract

The fourth component of human complement (C4) has been purified in 20% yield from fresh plasma using as starting material the 5-12% poly(ethylene glycol) precipitate which had been depleted of plasminogen by an affinity adsorbent. Sequential ion-exchange chromatography on diethylaminoethylcellulose, QAE-Sephadex, and DEAE-Bio-Gel A resulted in C4 homogeneous by immunological criteria and by polyacrylamide gel electrophoresis, the last chromatographic step achieving separation of native from inactivated C4. Reduction with 20 mM dithiothreitol for 2 h at 37 degrees C in 0.25 M 2-amino-2-hydroxymethyl-1,3-propanediol hydrochloride, pH 8.6, effected cleavage of the interchain disulfide bonds. A three-chain structure for C4 was confirmed, and molecular weight estimates of 93 000 +/- 9300, 75 000 +/- 7500, and 30 000 +/- 3000 determined for the alpha, beta, and gamma chains, respectively. The effects of known inactivators of C4 upon the chains of C4 were investigated, confirming that the inactivations by C1s and trypsin were accompanied by the fragmentation of the alpha chain. Inactivation of C4 by hydrazine, on the other hand, produced no detectable change in chain size. Separation of the chains was accomplished by gel filtration in the presence of 1 M acetic acid. Amino acid compositions of native C4 and the constitutive chains have been performed, and N-terminal sequences of the latter established by automated Edman degradation.

摘要

人补体第四成分(C4)已从新鲜血浆中以20%的产率纯化出来。起始材料是经亲和吸附剂去除纤溶酶原的5%-12%聚乙二醇沉淀物。依次在二乙氨基乙基纤维素、QAE-葡聚糖凝胶和二乙氨基乙基琼脂糖凝胶上进行离子交换色谱,得到的C4根据免疫学标准和聚丙烯酰胺凝胶电泳判断是均一的,最后一步色谱实现了天然C4与失活C4的分离。在0.25M盐酸2-氨基-2-羟甲基-1,3-丙二醇(pH 8.6)中,于37℃用20mM二硫苏糖醇还原2小时,可使链间二硫键断裂。证实了C4的三链结构,分别测定α、β和γ链的分子量估计值为93000±9300、75000±7500和30000±3000。研究了已知的C4灭活剂对C4各链的影响,证实C1s和胰蛋白酶引起的灭活伴随着α链的断裂。另一方面,肼对C4的灭活未使链大小发生可检测到的变化。在1M乙酸存在下通过凝胶过滤实现各链的分离。已测定天然C4及其组成链的氨基酸组成,并通过自动Edman降解确定了后者的N端序列。

相似文献

1
Purification and structural analysis of the fourth component of human complement.人补体第四成分的纯化及结构分析
Biochemistry. 1977 May 3;16(9):2008-15. doi: 10.1021/bi00628a039.
2
Isolation of component C4 of human complement and its polypeptide chains.人补体C4成分及其多肽链的分离
Eur J Biochem. 1981 Jun;117(1):141-6. doi: 10.1111/j.1432-1033.1981.tb06312.x.
3
The purification and characterization of bovine C4, the fourth component of complement.牛补体第四成分C4的纯化与特性分析
Biochem J. 1979 Mar 1;177(3):959-65. doi: 10.1042/bj1770959.
4
Purification and characterisation of the fourth component of bovine complement.牛补体第四成分的纯化与特性分析
Complement. 1987;4(1):1-11. doi: 10.1159/000463002.
5
The isolation and structure of C4, the fourth component of human complement.人补体第四成分C4的分离与结构
Biochem J. 1977 Sep 1;165(3):439-46. doi: 10.1042/bj1650439.
6
Third component of human complement: purification from plasma and physicochemical characterization.人类补体的第三成分:从血浆中纯化及理化特性分析
Biochemistry. 1976 Oct 5;15(20):4513-21. doi: 10.1021/bi00665a028.
7
Pro-C4 of human plasma: isolation and description of chemical and antigenic properties.人血浆中的前C4:化学和抗原特性的分离与描述
Ann N Y Acad Sci. 1980;343:252-65. doi: 10.1111/j.1749-6632.1980.tb47256.x.
8
Isolation of the fourth component (C4) of rat complement.
J Immunol. 1979 Nov;123(5):2261-4.
9
Purification of the fourth, second and fifth components of mouse complement.小鼠补体第四、第二和第五成分的纯化
Immunology. 1984 Mar;51(3):493-501.
10
Purification and characterisation of ovine C4: evidence for two molecular forms in ovine plasma.绵羊C4的纯化与特性分析:绵羊血浆中两种分子形式的证据
Mol Immunol. 1988 Jun;25(6):577-84. doi: 10.1016/0161-5890(88)90080-6.

引用本文的文献

1
Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.补体系统的辅助激活及其在临床状况病理生理学中的重要性。
Semin Immunopathol. 2018 Jan;40(1):87-102. doi: 10.1007/s00281-017-0646-9. Epub 2017 Sep 12.
2
Inhibition of human complement by beta-glycyrrhetinic acid.β-甘草次酸对人补体的抑制作用。
Immunology. 1997 Jan;90(1):115-20. doi: 10.1046/j.1365-2567.1997.00131.x.
3
Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway.
甘露糖结合蛋白识别胶质瘤细胞:通过凝集素途径对胶质瘤细胞补体激活的体外分析
Jpn J Cancer Res. 1995 Feb;86(2):187-92. doi: 10.1111/j.1349-7006.1995.tb03038.x.
4
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.系统性红斑狼疮患者红细胞中的补体受体(CR1)缺陷。
J Exp Med. 1982 May 1;155(5):1427-38. doi: 10.1084/jem.155.5.1427.
5
Amino acid sequence homologies and glycosylation differences between the fourth component of murine complement and sex-limited protein.小鼠补体第四成分与性限制蛋白之间的氨基酸序列同源性及糖基化差异。
Proc Natl Acad Sci U S A. 1982 Oct;79(20):6347-9. doi: 10.1073/pnas.79.20.6347.
6
Covalent binding and hemolytic activity of complement proteins.补体蛋白的共价结合与溶血活性
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7194-8. doi: 10.1073/pnas.77.12.7194.
7
Purification of the fourth, second and fifth components of mouse complement.小鼠补体第四、第二和第五成分的纯化
Immunology. 1984 Mar;51(3):493-501.
8
Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.C4结合蛋白与细胞结合型C4b的相互作用。结合的定量分析以及C4结合蛋白在细胞结合型C4b蛋白水解中的作用。
J Exp Med. 1983 Apr 1;157(4):1239-51. doi: 10.1084/jem.157.4.1239.
9
Polymorphism of human erythrocyte C3b/C4b receptor.人类红细胞C3b/C4b受体的多态性
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1698-702. doi: 10.1073/pnas.80.6.1698.
10
Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from major plasma form.人补体第四成分分泌形式的鉴定及部分特性分析:证明其与主要血浆形式不同。
Proc Natl Acad Sci U S A. 1983 Jan;80(1):268-72. doi: 10.1073/pnas.80.1.268.